| Dr Bradley Leone Shoss, MD | |
|
160 Boston Ave, Altamonte Springs, FL 32701-4706 | |
| (407) 339-0303 | |
| (407) 339-0961 |
| Full Name | Dr Bradley Leone Shoss |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 13 Years |
| Location | 160 Boston Ave, Altamonte Springs, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013203272 | NPI | - | NPPES |
| 018716300 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 2015007985 (Missouri) | Secondary |
| 207W00000X | Ophthalmology | ME127081 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Orlando | Orlando, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Florida Eye Clinic P A | 6406758846 | 25 |
News Archive
A final analysis of the Phase 3 COU-AA-302 trial presented today at the European Society for Medical Oncology (ESMO) 2014 Congress in Madrid, Spain showed that ZYTIGA® (abiraterone acetate) plus prednisone significantly prolonged overall survival (OS), compared to an active control of placebo plus prednisone, in men with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC).
As part of a scheme by the Department of Health students may be getting to know their school nurses better. Using technology such as text messaging, emails and mobile phone apps to contact their school nurse could be used to overcome problems of setting up appointments.
Genzyme Corp. announced today that ongoing discussions with Sanofi-Aventis have progressed to the point where Genzyme's board has authorized the company to enter into a confidentiality agreement with Sanofi-Aventis in order to allow Sanofi to conduct due diligence. Discussions between Genzyme's advisors and Sanofi's advisors and between Genzyme and Sanofi representatives are continuing.
A review published in Chemo-Biological Interactions has focused on the prevalence of COVID-19 in CVD patients associated with ACE2 mechanisms.
Several newspapers recently published articles that examined the health care proposals of presidential candidates Sens. Hillary Rodham Clinton (D-N.Y), Barack Obama (D-Ill.) and John McCain (R-Ariz.).
› Verified 5 days ago
| Entity Name | Florida Eye Clinic P A |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417921180 PECOS PAC ID: 6406758846 Enrollment ID: O20040126000005 |
News Archive
A final analysis of the Phase 3 COU-AA-302 trial presented today at the European Society for Medical Oncology (ESMO) 2014 Congress in Madrid, Spain showed that ZYTIGA® (abiraterone acetate) plus prednisone significantly prolonged overall survival (OS), compared to an active control of placebo plus prednisone, in men with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC).
As part of a scheme by the Department of Health students may be getting to know their school nurses better. Using technology such as text messaging, emails and mobile phone apps to contact their school nurse could be used to overcome problems of setting up appointments.
Genzyme Corp. announced today that ongoing discussions with Sanofi-Aventis have progressed to the point where Genzyme's board has authorized the company to enter into a confidentiality agreement with Sanofi-Aventis in order to allow Sanofi to conduct due diligence. Discussions between Genzyme's advisors and Sanofi's advisors and between Genzyme and Sanofi representatives are continuing.
A review published in Chemo-Biological Interactions has focused on the prevalence of COVID-19 in CVD patients associated with ACE2 mechanisms.
Several newspapers recently published articles that examined the health care proposals of presidential candidates Sens. Hillary Rodham Clinton (D-N.Y), Barack Obama (D-Ill.) and John McCain (R-Ariz.).
› Verified 5 days ago
| Entity Name | Florida Eye Clinic Ambulatory Surgery Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376513440 PECOS PAC ID: 0749177822 Enrollment ID: O20040303000192 |
News Archive
A final analysis of the Phase 3 COU-AA-302 trial presented today at the European Society for Medical Oncology (ESMO) 2014 Congress in Madrid, Spain showed that ZYTIGA® (abiraterone acetate) plus prednisone significantly prolonged overall survival (OS), compared to an active control of placebo plus prednisone, in men with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC).
As part of a scheme by the Department of Health students may be getting to know their school nurses better. Using technology such as text messaging, emails and mobile phone apps to contact their school nurse could be used to overcome problems of setting up appointments.
Genzyme Corp. announced today that ongoing discussions with Sanofi-Aventis have progressed to the point where Genzyme's board has authorized the company to enter into a confidentiality agreement with Sanofi-Aventis in order to allow Sanofi to conduct due diligence. Discussions between Genzyme's advisors and Sanofi's advisors and between Genzyme and Sanofi representatives are continuing.
A review published in Chemo-Biological Interactions has focused on the prevalence of COVID-19 in CVD patients associated with ACE2 mechanisms.
Several newspapers recently published articles that examined the health care proposals of presidential candidates Sens. Hillary Rodham Clinton (D-N.Y), Barack Obama (D-Ill.) and John McCain (R-Ariz.).
› Verified 5 days ago
| Entity Name | Florida Eye Clinic Ambulatory Surgery Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1376513440 PECOS PAC ID: 0749177822 Enrollment ID: O20120405000350 |
News Archive
A final analysis of the Phase 3 COU-AA-302 trial presented today at the European Society for Medical Oncology (ESMO) 2014 Congress in Madrid, Spain showed that ZYTIGA® (abiraterone acetate) plus prednisone significantly prolonged overall survival (OS), compared to an active control of placebo plus prednisone, in men with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC).
As part of a scheme by the Department of Health students may be getting to know their school nurses better. Using technology such as text messaging, emails and mobile phone apps to contact their school nurse could be used to overcome problems of setting up appointments.
Genzyme Corp. announced today that ongoing discussions with Sanofi-Aventis have progressed to the point where Genzyme's board has authorized the company to enter into a confidentiality agreement with Sanofi-Aventis in order to allow Sanofi to conduct due diligence. Discussions between Genzyme's advisors and Sanofi's advisors and between Genzyme and Sanofi representatives are continuing.
A review published in Chemo-Biological Interactions has focused on the prevalence of COVID-19 in CVD patients associated with ACE2 mechanisms.
Several newspapers recently published articles that examined the health care proposals of presidential candidates Sens. Hillary Rodham Clinton (D-N.Y), Barack Obama (D-Ill.) and John McCain (R-Ariz.).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bradley Leone Shoss, MD 160 Boston Ave, Altamonte Springs, FL 32701-4706 Ph: (407) 775-7654 | Dr Bradley Leone Shoss, MD 160 Boston Ave, Altamonte Springs, FL 32701-4706 Ph: (407) 339-0303 |
News Archive
A final analysis of the Phase 3 COU-AA-302 trial presented today at the European Society for Medical Oncology (ESMO) 2014 Congress in Madrid, Spain showed that ZYTIGA® (abiraterone acetate) plus prednisone significantly prolonged overall survival (OS), compared to an active control of placebo plus prednisone, in men with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC).
As part of a scheme by the Department of Health students may be getting to know their school nurses better. Using technology such as text messaging, emails and mobile phone apps to contact their school nurse could be used to overcome problems of setting up appointments.
Genzyme Corp. announced today that ongoing discussions with Sanofi-Aventis have progressed to the point where Genzyme's board has authorized the company to enter into a confidentiality agreement with Sanofi-Aventis in order to allow Sanofi to conduct due diligence. Discussions between Genzyme's advisors and Sanofi's advisors and between Genzyme and Sanofi representatives are continuing.
A review published in Chemo-Biological Interactions has focused on the prevalence of COVID-19 in CVD patients associated with ACE2 mechanisms.
Several newspapers recently published articles that examined the health care proposals of presidential candidates Sens. Hillary Rodham Clinton (D-N.Y), Barack Obama (D-Ill.) and John McCain (R-Ariz.).
› Verified 5 days ago
Dr. Miguel Lugo, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 661 E Altamonte Dr, Suite 223, Altamonte Springs, FL 32701 Phone: 407-260-2255 Fax: 407-260-2831 | |
Dr. Jose J Echegaray, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 616 E Altamonte Dr Ste 101, Altamonte Springs, FL 32701 Phone: 407-637-2096 Fax: 407-637-2097 | |
Dr. Tal Manor Kazam, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 160 Boston Ave # 32701, Altamonte Springs, FL 32701 Phone: 407-775-7654 Fax: 407-339-1203 | |
Harry R Pappas, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 160 Boston Ave, Altamonte Springs, FL 32701 Phone: 407-834-7776 Fax: 407-834-0973 | |
Thomas O Steedle, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 160 Boston Ave, Altamonte Springs, FL 32701 Phone: 407-834-7776 Fax: 407-834-0973 | |
Osama Hassan Omar, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 220 N Westmonte Dr Ste F, Altamonte Springs, FL 32714 Phone: 407-389-0800 Fax: 407-389-1880 |